Exendin-4, a GLP-1 receptor agonist, stimulates entero-insular axis in the rat, through a mechanism involving adrenal medulla

M. Nowak,A. Zyterska,C. Macchi,L. Malendowicz,G. Nussdorfer,K. Nowak
DOI: https://doi.org/10.2220/BIOMEDRES.22.295
2001-12-01
Abstract:Glucagon-like peptide-1 (GLP-1) is known to lower blood glucose level, the effect depending on the stimulation of insulin and the inhibition of glucagon secretion. Due to the rapid inactivation of GLP-1 by dipeptidyl peptidase-IV (DPP-IV), its biological action is very short. Hence, we investigated the effect on rat entero-insular axis of exendin-4, a DPP-IV-resistant agonist of GPL-1 receptors. As expected the bolus administration of exendin-4 (12 nmol/kg) increased the plasma concentration of insulin and decreased the blood levels of both glucagon and leptin in normal rats; however, GLP-1 raised glycemia. Exendin-4 did not evoke any effect in rats bearing enucleated-regenerated adrenals deprived of medullary tissue, thereby suggesting that its stimulating effect of entero-insular axis occurs via an indirect mechanism probably involving medullary catecholamines. Catecholamines are potent stimulator of hepatic glycogenolysis, and this may tentatively explain the hyperglycemizing effect of exendin-4.
Biology,Medicine
What problem does this paper attempt to address?